Search alternatives:
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
7921
Long-term changes in ABG parameters retrospectively tracked from the initiation of LTOT in the CRF group.
Published 2025“…<p>From five years prior to the initiation of LTOT, a decrease in PaO<sub>2</sub> and PaCO<sub>2</sub>, accompanied by an increase in A-aDO<sub>2</sub>, was observed. …”
-
7922
Statistical summaries.
Published 2025“…This may indicate that infection causes a decrease in the effectiveness of primarily antioxidant mechanisms, whereas immune mechanisms are still activated during infection. …”
-
7923
Supplementary Material for: High-sensitivity Troponin I Measurement in a Large Contemporary Cohort: Implications for Clinical Care
Published 2025“…Male sex, higher HDL-C, higher Hgb A1c, decreasing eGFR, and increasing systolic blood pressure were significant predictors of increased hsTnI. …”
-
7924
A fast <i>in situ</i> hybridization chain reaction method in <i>Drosophila</i> embryos and ovaries
Published 2024“…We present a rapid isHCR method for <i>Drosophila</i> embryos and ovaries. …”
-
7925
Enteropathogen detection and fCal levels.
Published 2025“…<div><p>Diarrheal disease is a leading cause of death among young children globally. …”
-
7926
Identification of multicohort-based predictive signature for NMIBC recurrence reveals SDCBP as a novel oncogene in bladder cancer
Published 2025“…<p>Despite surgical and intravesical chemotherapy interventions, non-muscle invasive bladder cancer (NMIBC) poses a high risk of recurrence, which significantly impacts patient survival. …”
-
7927
DataSheet2_Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis.docx
Published 2024“…Although the population of F4/80<sup>+</sup>CD11b<sup>+</sup> intrahepatic mononuclear phagocytes remained unchanged, their infiltration and activation (CHIT1<sup>+</sup>MerTK<sup>+</sup>) significantly decreased in OATD-01-treated mice, compared with that observed in vehicle-treated mice.…”
-
7928
DataSheet1_Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis.zip
Published 2024“…Although the population of F4/80<sup>+</sup>CD11b<sup>+</sup> intrahepatic mononuclear phagocytes remained unchanged, their infiltration and activation (CHIT1<sup>+</sup>MerTK<sup>+</sup>) significantly decreased in OATD-01-treated mice, compared with that observed in vehicle-treated mice.…”
-
7929
-
7930
Supplementary Material for: Phoxilium® as a Phosphate-Sparing Solution for Continuous Renal Replacement Therapy in Paracetamol-Induced Acute Liver Failure
Published 2025“…Phoxilium® patients experienced a small but significant decrease in median arterial pH and standard base excess, which remained within normal limits, but lower than with Accusol® (p = 0.018 and p = 0.046, respectively). …”
-
7931
<i>DANCR</i> is a clinically important MITF and c-MYC regulated lncRNA in human melanoma.
Published 2025“…<i>POLII</i> was used as a reference gene. Results presented as mean + /- SEM., n ≥ 2; Two-tailed two sample t-test p < 0.05*, p < 0.01**, p < 0.001***. …”
-
7932
Photon budgets and the effects of relative CDOM and pigment absorptions on primary production along a coastal salinity gradient
Published 2024“…The absorption by CDOM and detritus decreased with increasing salinity, while phytoplankton absorption followed a seasonal succession. …”
-
7933
Supplementary Material for: Anti-Vascular Endothelial Growth Factor Treatment Outcomes in Macular Telangiectasia: A Systematic Review
Published 2025“…CCT in proliferative MacTel eyes decreased from 272.37 (52.65) µm and 247.40 (48.80) µm on anti-VEGF therapy. …”
-
7934
Characterization of <i>S. japonicus pab</i>2Δ.
Published 2025“…Data are presented as mean ± SD from three independent experiments. Statistical significance was determined using a two-tailed unpaired <i>t</i>-test (*<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.005; N.S.: not significant). …”
-
7935
Clinical features.
Published 2025“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”
-
7936
Study design.
Published 2025“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”
-
7937
Antimicrobial Treatments.
Published 2025“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”
-
7938
Routine sporotrichosis laboratory tests.
Published 2025“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”
-
7939
Patient characteristics.
Published 2025“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”
-
7940
Supplementary Material for: Patients with Opioid Use Disorder Choosing Treatment with Extended-Release Naltrexone: A 6-Months Naturalistic Study
Published 2024“…The majority of the MITT population (84; 60.9%) completed 24 weeks of treatment in the study. There was a significant decrease in the overall use of opioids (p<0.001) and the use of alcohol and other illicit substances was low. …”